您当前位置：首页 > 国际期刊-Frontiers in Bioengineering and Biotechnology期刊投稿发表详细信息

Frontiers in Bioengineering and Biotechnology Q1

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
2296-4185
期刊简拼：
FRONT BIOENG BIOTECH
年发文章数：
1559
E-ISSN：
Gold OA文章占比
99.42%
研究文章占比：
76.91%
是否OA：
Yes
Jcr分区：
Q1
中科院分区：
3区

出版信息

出版商：
Frontiers Media S.A.
涉及研究方向：
Chemical Engineering-Bioengineering
出版国家：
Switzerland
出版语言：
English
出版周期：
出版年份：

2023-2024最新影响因子:4.3
自引率:4.70%
五年影响因子:5.1
JCI期刊引文指标:0.83
h-index:暂无h-index数据
CiteScore:8.30

期刊关键词

1区 SCIE Scopus DOAJ 工程技术 3区 MULTIDISCIPLINARY SCIENCES 综合性期刊

期刊简介

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

《Frontiers in Bioengineering and Biotechnology》期刊已被查看：次
期刊简写：FRONT BIOENG BIOTECH

此期刊被最新的JCR期刊SCIE收录